Clinical Trials Browser

Phase 3 × Not yet recruiting × Prostate Cancer Recurrent × Clear all

NCT06922929 2025-04-11

A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

Phase 3 Not yet recruiting

Prostate Cancer Recurrent